Quarterly report · Q2
4891.TEDINET S100S0XZ
Period2023-03-01 → 2023-08-31
Filed2023-10-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥345m | 2023-03-01 → 2023-08-31 | Standalone | Operating income |
| Operating income | −¥269m | 2022-03-01 → 2022-08-31 | Standalone | Operating income |
| Ordinary income | −¥342m | 2023-03-01 → 2023-08-31 | Standalone | Ordinary income |
| Ordinary income | −¥861m | 2022-03-01 → 2023-02-28 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥469m | 2022-03-01 → 2022-08-31 | Standalone | Ordinary income |
| Profit before tax | −¥342m | 2023-03-01 → 2023-08-31 | Standalone | Income before income taxes |
| Profit before tax | −¥469m | 2022-03-01 → 2022-08-31 | Standalone | Income before income taxes |
| Net income | −¥343m | 2023-03-01 → 2023-08-31 | Standalone | Profit loss |
| Net income | −¥861m | 2022-03-01 → 2023-02-28 | Standalone | Net income loss (5-year summary) |
| Net income | −¥468m | 2022-03-01 → 2022-08-31 | Standalone | Profit loss |
| Total assets | ¥3.4bn | at 2023-08-31 | Standalone | Assets |
| Total assets | ¥3.8bn | at 2023-02-28 | Standalone | Assets |
| Total assets | ¥2.1bn | at 2022-08-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥61m | at 2023-08-31 | Standalone | Liabilities |
| Total liabilities | ¥76m | at 2023-02-28 | Standalone | Liabilities |
| Net assets / equity | ¥3.4bn | at 2023-08-31 | Standalone | Net assets |
| Net assets / equity | ¥3.7bn | at 2023-02-28 | Standalone | Net assets |
| Net assets / equity | ¥2.0bn | at 2022-08-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2023-08-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.6bn | at 2023-02-28 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.2bn | at 2023-08-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2023-02-28 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2022-08-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2022-02-28d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥337m | 2023-03-01 → 2023-08-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥688m | 2022-03-01 → 2023-02-28 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥364m | 2022-03-01 → 2022-08-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥2m | 2023-03-01 → 2023-08-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥14m | 2022-03-01 → 2023-02-28 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7m | 2022-03-01 → 2022-08-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥2m | 2023-03-01 → 2023-08-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.7bn | 2022-03-01 → 2023-02-28 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥233m | 2022-03-01 → 2022-08-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-9.37 | 2023-03-01 → 2023-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.3 | 2023-06-01 → 2023-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.28 | 2022-03-01 → 2023-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.14 | 2022-03-01 → 2022-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6 | 2022-06-01 → 2022-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 98.1% | at 2023-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 98.0% | at 2023-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.5% | at 2022-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 36,594,880 | at 2023-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 36,574,880 | at 2023-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 33,102,080 | at 2022-08-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 349
| Item | Context | Value | Unit |
|---|---|---|---|
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)東京都中央区日本橋２丁目３－４ | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)ＴＨＶＰ－１号投資事業有限責任組 合 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)宮城県仙台市青葉区荒巻字青葉４６８－ １ | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)ニッセイ・キャピタル９号投資事業 有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内２丁目３－２ 郵船ビルディング | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)ニッセイ・キャピタル７号投資事業 有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内２丁目３－２ 郵船ビルディング | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)株式会社新日本科学 | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)鹿児島県鹿児島市宮之浦町２４３８ | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)Ｘｓｅｅｄ Ｈｉｇｈ Ｇｒｏｗｔｈ 投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)東京都千代田区九段北３丁目２－４ | |
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)ＭＳＩＶＣ２０１６Ｖ投資事業有限 責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)東京都中央区京橋１丁目２－５ 京橋ＴＤビル４Ｆ | |
| Name major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)ＯＣＰ１号投資事業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)東京都中央区日本橋本町１丁目５－４ 住友不動産日本橋ビル７階 | |
| Name major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)ニッセイ・キャピタル１０号投資事 業有限責任組合 | |
| Address major shareholders | CurrentQuarterInstant_No10MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内２丁目３－２ 郵船ビルディング | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は子会社がありませんので、四半期連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding research and development expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | Prior1YTDDuration_NonConsolidatedMember | Original text (Japanese)当社は、医薬品開発事業のみの単一セグメントであるため、記載を省略しております。 | |
| Description of fact that companys business comprises single segment | CurrentYTDDuration_NonConsolidatedMember | Original text (Japanese)当社は、医薬品開発事業のみの単一セグメントであるため、記載を省略しております。 | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |